Skip to Content

Antibody Alternative

In the last decade, antibody-based drugs have provided treatments for allergies, infectious diseases, cancers, and autoimmune diseases such as rheumatoid arthritis. But antibodies are large molecules, expensive to manufacture and tricky to maintain, requiring refrigerated storage. And extensive patent protections tie the hands of drug companies that want to expand their use.

Now researchers at biotech startup Avidia, in Mountain View, CA, have engineered a new class of proteins they call “avimers,” which the company says are easier to make and store – and require fewer lawyers to bring to market. Avidia scientists have shown that an avimer designed to inhibit human interleukin-6 (IL-6) – a protein implicated in rheumatoid arthritis and Crohn’s disease – works in mice. Avidia plans to move the avimer into human trials later this year.

Avimers derive from a related group of about 200 human-protein subunits. In the body, collections of these subunits fit together like Legos to form proteins that bind to small molecules and other proteins – exactly what any drug must do. Avidia scientists have varied the molecules’ building blocks to create a vast “library” of more than 100 million billion subunits. Linking together differing numbers and types of the variants “allows you to engineer proteins with a desired specificity for a target and to get very high affinities,” says George Georgiou, a protein engineer at the University of Texas at Austin.

Avidia scientists say they can design molecules to either inhibit or activate their targets and perhaps even bind to multiple targets simultaneously. Josh Silverman, an Avidia senior scientist, says the company’s initial sights are on drugs for cancers and autoimmune diseases.

Keep Reading

Most Popular

The Steiner tree problem:  Connect a set of points with line segments of minimum total length.
The Steiner tree problem:  Connect a set of points with line segments of minimum total length.

The 50-year-old problem that eludes theoretical computer science

A solution to P vs NP could unlock countless computational problems—or keep them forever out of reach.

section of Rima Sharp captured by the LRO
section of Rima Sharp captured by the LRO

The moon didn’t die as early as we thought

Samples from China’s lunar lander could change everything we know about the moon’s volcanic record.

conceptual illustration of a heart with an arrow going in on one side and a cursor coming out on the other
conceptual illustration of a heart with an arrow going in on one side and a cursor coming out on the other

Forget dating apps: Here’s how the net’s newest matchmakers help you find love

Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.

ASML machine
ASML machine

Inside the machine that saved Moore’s Law

The Dutch firm ASML spent $9 billion and 17 years developing a way to keep making denser computer chips.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.